Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Identify what to focus on for retirement in your 40s. Stay proactive in securing your financial well-being as you age.
22,435 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Futures markets show how traders see the near-term path for oil, stocks, and currencies. This explainer breaks down t...
Banks are boosting checking account bonuses to attract new customers. This report breaks down how to qualify, what to...
SpaceX's Starlink program could redefine internet access and investor value. This year’s launch pace hinges on regula...
Cross-border investing in Europe can be tricky because taxes are taken at the source. This guide explains how withhol...
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
Two parallel paths are emerging in legal AI: one focused on enterprise rigor and governance, the other on broad, open...
As the S&P 500 slides 2.5% this month, three Bitcoin ETFs show varied, stubborn strength. IBIT and BITB post solid ga...
A Middle East conflict is lifting borrowing costs for American homebuyers as mortgage rates rise amid higher energy p...
Investors are watching PLBY closely as plby (plby) 2026 earnings unfold. This article breaks down Q1 results, evaluat...
Retail traders are adopting a pared-down framework called the three-circle test: don’t need to be a CEO to pick winni...
A major payer shift could unlock stronger demand for Eli Lilly’s obesity and GLP-1 products. This in-depth analysis e...